Taurine Alleviates the Progression of Diabetic Nephropathy in Type 2 Diabetic Rat Model

Table 1

Biochemical characteristics in experimental groups.

	LETO	OLETF	OLETF + TA
FBG (mg/dL)	90.1±1.36	171.1±14.32^∗	119.3±10.94^†
Insulin (ng/mL)	2.5±0.65	1.0±0.45^∗	1.6±0.59^∗,†
Kitt (%/min)	5.9±0.36	1.6±0.49^∗	2.3±0.54^∗
HOMA-IR	30.38±2.64	26.12±3.30	27.9±5.47
HOMA-𝛽	1908±249.4	258.7±65.23^∗	726.8±133.03^∗,†
ADP (𝜇g/mL)	7.3±1.12	5.9±1.39^∗	6.6±1.16

Data are expressed as mean ± SEM.; ADP: adiponectin; FBG: fasting blood glucose; HOMA-β: homeostasis model assessment for beta-cell function; HOMA-IR: homeostasis model assessment for insulin resistance; Kitt: short insulin tolerance test; LETO: normal control group; OLETF: diabetic control group; OLETF + TA: taurine-treated diabetic group. ^∗𝑃<0.05 compared with LETO; ^†𝑃<0.05 compared with OLETF.